Swirsky Douglas J 4
4 · Cellectar Biosciences, Inc. · Filed Jun 28, 2023
Insider Transaction Report
Form 4
Swirsky Douglas J
Director
Transactions
- Award
Stock option (right to buy)
2023-06-28+37,500→ 71,925 totalExercise: $1.85Exp: 2033-06-28→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]This stock option shall vest in full on June 28, 2024, subject to the reporting person's continued service through the applicable vesting date.